| n = 46 | |
| Age, years (mean ± SD) | 59.1 ± 12.4 |
| Female, n (%) | 28 (60.8%) |
| Body Mass Index, Kg/m2 (mean ± SD) | 26 ± 4.4 |
| STS score | |
| Low risk, n (%) | 38 (82.6%) |
| Intermidiary risk, n (%) | 8 (17.3%) |
| High risk, n (%) | 0 |
| Diabetes Mellitus, n (%) | 6 (13.4%) |
| Systemic arterial hypertension, n (%) | 25 (54.3%) |
| Atrial fibrillation, n (%) | 13 (28.2%) |
| Peripheral vascular didease, n (%) | 1 (2.1%) |
| eGFR < 60 ml/min/1.73m2, n (%) | 3 (6.5%) |
| Stroke, n (%) | 5 (10.8%) |
| Transient ischaemic attack, n (%) | 1 (2.1%) |
| Myocardial infarction, n (%) | 1 (2.1%) |
| Coronary atherosclerotic disease, n (%) | 3 (6.5%) |
| Myocardial revascularization, n (%) | 3 (6.5%) |
| Chronic obstructive pulmonar disease, n (%) | 4 (8.6%) |
| Endocarditis, n (%) | 1 (2.1%) |
| Left Atrium size, mm (mean ± SD) | 49.4 ± 7.6 |
| EDDLV, mm (mean ± SD) | 53.7 ± 7.6 |
| Left ventricular ejection fraction | |
| ≤40%, n (%) | 0 |
| 41% - 49%, n (%) | 1 (2.1%) |
| ≥50%, n (%) | 43 (93.7%) |
| Not found | 2 (4.3%) |
| Probability for PAH | |
| Low probability, n (%) | 13 (28.2%) |
| Moderate probability, n (%) | 8 (17.4%) |
| High probability, n (%) | 22 (48%) |
| Not found | 3 (6.4%) |